Literature DB >> 15251667

Pituitary apoplexy after anticoagulation for unstable angina.

A S Willamowicz1, R L Houlden.   

Abstract

OBJECTIVE: To describe a patient with an undiagnosed pituitary macroadenoma, in whom pituitary apoplexy developed after heparin anticoagulation for treatment of unstable angina.
METHODS: We chronicle the clinical course, treatment, and outcome in a 53-year-old woman with pituitary apoplexy. Potential risk factors are also discussed.
RESULTS: In a patient with coronary artery disease and unstable angina, heparin anticoagulation therapy was initiated. Shortly thereafter, severe frontal headaches, nausea and vomiting, high fever, diplopia, and visual field deficits developed. A workup for infectious causes and analysis of cerebrospinal fluid were negative. Contrast-enhanced computed tomography of the head revealed a pituitary macroadenoma with a central area of hemorrhage, and pituitary apoplexy was diagnosed. Hydrocortisone sodium succinate was administered intravenously, and ultimately, transsphenoidal resection was performed. Postoperatively, diabetes insipidus developed and persisted. Neurologically, she had near-total blindness of the right eye and temporal hemianopia of the left eye.
CONCLUSION: Although pituitary apoplexy is rare, its occurrence can be associated with certain risk factors, including anticoagulation. Clinicians should be aware of this serious condition so that timely diagnosis and treatment can provide the best chance of recovery.

Entities:  

Year:  1999        PMID: 15251667     DOI: 10.4158/EP.5.5.273

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  4 in total

1.  Surgical treatment for severe visual compromised patients after pituitary apoplexy.

Authors:  Chi-Cheng Chuang; Chen-Nen Chang; Kuo-Chen Wei; Cheng-Chih Liao; Peng-Wei Hsu; Ying-Cheng Huang; Yao-Liang Chen; Li-Ju Lai; Ping-Ching Pai
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

2.  Pituitary metastasis presenting as ischemic pituitary apoplexy following heparin-induced thrombocytopenia.

Authors:  Ivan Kruljac; Vatroslav Cerina; Hrvoje Ivan Pećina; Leo Pažanin; Tomas Matić; Velimir Božikov; Milan Vrkljan
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

Review 3.  Multidisciplinary Management of Pituitary Apoplexy.

Authors:  Adriana Albani; Francesco Ferraù; Filippo Flavio Angileri; Felice Esposito; Francesca Granata; Felicia Ferreri; Salvatore Cannavò
Journal:  Int J Endocrinol       Date:  2016-12-15       Impact factor: 3.257

4.  Clinical and biochemical characteristics of patients presenting with pituitary apoplexy.

Authors:  Ali Abbara; Sophie Clarke; Pei Chia Eng; James Milburn; Devavrata Joshi; Alexander N Comninos; Rozana Ramli; Amrish Mehta; Brynmor Jones; Florian Wernig; Ramesh Nair; Nigel Mendoza; Amir H Sam; Emma Hatfield; Karim Meeran; Waljit Singh Dhillo; Niamh M Martin
Journal:  Endocr Connect       Date:  2018-08-23       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.